We are live on ! Find out more
LPCN icon

Lipocine
LPCN

47 hedge funds and large institutions have $119M invested in Lipocine in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,039% more call options, than puts

Call options by funds: $752K | Put options by funds: $66K

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

9% more capital invested

Capital invested by funds: $109M → $119M (+$9.44M)

4% more funds holding

Funds holding: 45 → 47 (+2)

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

Holders
47
Holders Change
+2
Holders Change %
+4.44%
% of All Funds
1.23%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
13
Increased
14
Reduced
14
Closed
11
Calls
$752K
Puts
$66K
Net Calls
+$686K
Net Calls Change
+$686K

Top Buyers

1
CC
Carlson Capital
Texas
+$2.83M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.41M
3
EI
EAM Investors
California
+$721K
4
OAM
Oxford Asset Management
United Kingdom
+$673K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$596K

Top Sellers

1
VM
VHCP Management
New York
-$5.18M
2
RA
Royce & Associates
New York
-$2.44M
3
TC
TFS Capital
Pennsylvania
-$2.04M
4
RCM
Rotella Capital Management
Washington
-$1.23M
5
LOAMU
Lombard Odier Asset Management (USA)
New York
-$1.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$624K +$596K +2,840 New
Northern Trust
27
Northern Trust
Illinois
$607K +$185K +882 +47%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$595K +$568K +2,706 New
BFA
29
BlackRock Fund Advisors
California
$495K +$20.8K +99 +5%
ISL
30
Ingalls & Snyder LLC
New York
$389K -$2.1K -10 -0.6%
EMG
31
Ellington Management Group
Connecticut
$311K +$297K +1,417 New
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$202K +$193K +921 New
MC
33
Menta Capital
California
$176K +$30.6K +146 +22%
Deutsche Bank
34
Deutsche Bank
Germany
$173K -$128K -611 -44%
State Street
35
State Street
Massachusetts
$172K +$2.31K +11 +1%
Goldman Sachs
36
Goldman Sachs
New York
$151K -$95K -453 -40%
CS
37
Credit Suisse
Switzerland
$149K +$142K +677 New
Morgan Stanley
38
Morgan Stanley
New York
$87K -$690K -3,290 -89%
Wells Fargo
39
Wells Fargo
California
$78K +$74.3K +354 New
LTFS
40
Ladenburg Thalmann Financial Services
Florida
$54K – – –
BIM
41
BlackRock Investment Management
Delaware
$34K – – –
UBS Group
42
UBS Group
Switzerland
$28K +$22.7K +108 +540%
CG
43
Cutler Group
California
$28K +$27.1K +129 New
BA
44
BlackRock Advisors
Delaware
$22K +$21K +100 New
AIM
45
Advantage Investment Management
Iowa
$19K – – –
Citigroup
46
Citigroup
New York
$18K +$4.62K +22 +37%
Simplex Trading
47
Simplex Trading
Illinois
$2K +$2.52K +12 New
TC
48
TFS Capital
Pennsylvania
– -$2.04M -10,148 Closed
RCM
49
Rotella Capital Management
Washington
– -$1.23M -6,114 Closed
ARTA
50
A.R.T. Advisors
New York
– -$1.04M -5,155 Closed
1
2
3

LPCN Hedge Fund Activity: Q4 2015 in Review

47 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q4 2015, worth a combined $119M — up 8.6% from $109M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LPCN positions and 11 closed out — a net gain of 2 holders — while 14 added to existing stakes and 14 trimmed.

The largest buyer was Carlson Capital, opening a new position worth an estimated $2.83M. The largest seller was VHCP Management, cutting an estimated $5.18M.

  • 47 institutional investors held Lipocine (LPCN) as of Q4 2015, up from 45 in Q3 2015.
  • Funds reported $119M of Lipocine stock for Q4 2015, up 8.6% quarter-over-quarter.
  • 13 funds opened new Lipocine positions in Q4 2015 and 11 closed out, a net change of +2 holders.
  • The largest Lipocine buyer in Q4 2015 was Carlson Capital, an estimated $2.83M added.
  • The largest Lipocine seller in Q4 2015 was VHCP Management, an estimated $5.18M sold.

Based on aggregated 13F filings for Q4 2015.